promising clinical results obtained radiolabeled antibodies lymphoma patients higher uptake lymphomas 67gallium 67ga compared monoclonal antibodies makes selective radiotherapy widely available 67ga appealing gamma radiation 67ga used scintigraphy considered lymphoma cells addition photon radiation 67ga emits low energy auger electrons kev conversion electrons cytotoxic objective present study assessment radiotoxicity 67ga lymphoid cell line u937 proliferation clonogenic capacity measured NUMBER NUMBER days incubation NUMBER NUMBER NUMBER microci 67ga growth inhibition NUMBER NUMBER days incubation NUMBER NUMBER days incubation NUMBER microci 67ga clonogenic capacity reduced NUMBER NUMBER days NUMBER NUMBER days incubation NUMBER microci 67ga survival curve showed initial shoulder steeper pci low linear energy transfer type doses 67ga 90yttrium 90y determined dose NUMBER microci 67ga cumulative dose conversion electrons NUMBER cgy NUMBER microci 90y cumulative dose NUMBER cgy dose NUMBER microci 67ga NUMBER microci main cytotoxic effect 67ga induced NUMBER kev conversion electrons conclude conversion electrons 67ga cytotoxic effect u937 cells experiments higher 67ga 90y needed cytotoxic effect believe 67ga holds promise therapeutic use non toxic NUMBER NUMBER mtt assay cfu assay ml NUMBER ml NUMBER ml NUMBER NUMBER NUMBER cell NUMBER iso effect iso effect ml NUMBER ml NUMBER iso effect ml NUMBER NUMBER fold microci dose 90y ml